Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheng Chu

Showing results (491-500 of 585) with videos related to

Pageof 59
Sort By:
Psychiatry and Clinical Neurosciences|September 3, 2022
Diagnostic progression to schizophrenia: A nationwide cohort study of 11 170 adolescents and young adults with autism spectrum disorderTien-Wei Hsu, Che-Sheng Chu, Shih-Jen Tsai, et al.
Brain Research|July 30, 2005
Pranlukast, a cysteinyl leukotriene receptor-1 antagonist, protects against chronic ischemic brain injury and inhibits the glial scar formation in miceGuo-Liang Yu, Er-Qing Wei, Meng-Ling Wang, et al.
Psychiatry and Clinical Neurosciences|February 26, 2024
Comparing the performance of ChatGPT GPT-4, Bard, and Llama-2 in the Taiwan Psychiatric Licensing Examination and in differential diagnosis with multi-center psychiatristsDian-Jeng Li, Yu-Chen Kao, Shih-Jen Tsai, et al.
British Journal of Pharmacology|April 5, 2014
YC-1 inhibits proliferation of breast cancer cells by down-regulating EZH2 expression via activation of c-Cbl and ERKLing-Chu Chang, Hui-Yi Lin, Meng-Tung Tsai, et al.
Biomedicine|February 27, 2018
The molecular mechanism of contrast-induced nephropathy (CIN) and its link to in vitro studies on iodinated contrast media (CM)Jai-Sing Yang, Yan-Ru Peng, Shih-Chang Tsai, et al.
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
P2Y12 Inhibitor Monotherapy versus Conventional Dual Antiplatelet Therapy in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Meta-AnalysisWen-Han Feng, Yong-Chieh Chang, Yi-Hsiung Lin, et al.
The Science of the Total Environment|April 12, 2024
Dependence of evolution of Cyanobacteria superiority on temperature and nutrient use efficiency in a meso-eutrophic plateau lakeJing Cao, Yue Wu, Ze-Kun Li, et al.
Human & Experimental Toxicology|October 9, 2010
2-(3-Methoxyphenyl)-6, 7-methylenedioxoquinolin-4-one, a novel synthetic compound, inhibited migration and invasion in TSGH8301 human bladder cancer cellsKuang-Chi Lai, Shu-Chun Hsu, Jai-Sing Yang, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 5, 2013
Expression and prognostic value of VEGFR-2, PDGFR-β, and c-Met in advanced hepatocellular carcinomaJie Sheng Chu, Fei Jiao Ge, Bo Zhang, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 27, 2005
YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9Yi-Nan Liu, Shiow-Lin Pan, Chieh-Yu Peng, et al.
Pageof 59

Showing results (491-500 of 585) with videos related to

Sort By:
Pageof 59
Psychiatry and Clinical Neurosciences|September 3, 2022
Diagnostic progression to schizophrenia: A nationwide cohort study of 11 170 adolescents and young adults with autism spectrum disorderTien-Wei Hsu, Che-Sheng Chu, Shih-Jen Tsai, et al.
Brain Research|July 30, 2005
Pranlukast, a cysteinyl leukotriene receptor-1 antagonist, protects against chronic ischemic brain injury and inhibits the glial scar formation in miceGuo-Liang Yu, Er-Qing Wei, Meng-Ling Wang, et al.
Psychiatry and Clinical Neurosciences|February 26, 2024
Comparing the performance of ChatGPT GPT-4, Bard, and Llama-2 in the Taiwan Psychiatric Licensing Examination and in differential diagnosis with multi-center psychiatristsDian-Jeng Li, Yu-Chen Kao, Shih-Jen Tsai, et al.
British Journal of Pharmacology|April 5, 2014
YC-1 inhibits proliferation of breast cancer cells by down-regulating EZH2 expression via activation of c-Cbl and ERKLing-Chu Chang, Hui-Yi Lin, Meng-Tung Tsai, et al.
Biomedicine|February 27, 2018
The molecular mechanism of contrast-induced nephropathy (CIN) and its link to in vitro studies on iodinated contrast media (CM)Jai-Sing Yang, Yan-Ru Peng, Shih-Chang Tsai, et al.
Pharmaceuticals (Basel, Switzerland)|June 1, 2023
P2Y12 Inhibitor Monotherapy versus Conventional Dual Antiplatelet Therapy in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Meta-AnalysisWen-Han Feng, Yong-Chieh Chang, Yi-Hsiung Lin, et al.
The Science of the Total Environment|April 12, 2024
Dependence of evolution of Cyanobacteria superiority on temperature and nutrient use efficiency in a meso-eutrophic plateau lakeJing Cao, Yue Wu, Ze-Kun Li, et al.
Human & Experimental Toxicology|October 9, 2010
2-(3-Methoxyphenyl)-6, 7-methylenedioxoquinolin-4-one, a novel synthetic compound, inhibited migration and invasion in TSGH8301 human bladder cancer cellsKuang-Chi Lai, Shu-Chun Hsu, Jai-Sing Yang, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 5, 2013
Expression and prognostic value of VEGFR-2, PDGFR-β, and c-Met in advanced hepatocellular carcinomaJie Sheng Chu, Fei Jiao Ge, Bo Zhang, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 27, 2005
YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9Yi-Nan Liu, Shiow-Lin Pan, Chieh-Yu Peng, et al.
Pageof 59